Advanced modalities are used for
wounds where conventional treatment is insufficient in
diabetic foot patients. In this study, we investigated the effects of using
Epidermal growth factor (
EGF) and NPWTmodalities alone or in combination on the frequency and level of
amputation. In the retrospective study, which included 286 patients in total, 76 patients were referred with the decision of
amputation or
amputation was planned during hospitalization. After the treatments,
amputation and distalization of
amputation were found 73.3% and 33.3% in the conventional treatment patients. While 86.4%
amp and 18.2%
amp distalization were found in
negative pressure wound therapy (NPWT) only patients, this rate was 52.4% and 90.5% in EGF + NPWT patients, 50% and 83.3% in
EGF only patients. While
amp and distalization rates were found to be significantly better in those receiving only
EGF or EGF + NPWT (P = .015, P = .017 respectively for
amputation and P = .000 for distalization), no difference was found in those receiving
EGF and EGF + NPWT. As a result of our study, although npwt contributed positively to the number and level of
amputations compared to conventional treatment, a significant improvement was found in the number and level of amps when
EGF was used alone or combined with NPWT. With this result,
EGF was thought to be an important treatment modality that should be evaluated in
diabetic foot ulcers (DFUs) without
amputation decision.